'Previously viewing it as a fragmented and less useful part of the cancer journey, I now recognise, thanks to Flatiron's analytical approach, that data can be a force for good.'

Read more from Flatiron UK’s Patient Voices Panel Member, Bob White:
flatironhealth.co.uk/blog/prioritis…

Join experts from Flatiron Health, J&J Innovative Medicine & the Foundation for FDA Foundation for the FDA, for an Endpoints News webinar on Wed. May 22 to learn pragmatic approaches to PMC/PMRs & discuss key frameworks for impactful #RWE generation.

Register now: webinars.endpts.com/how-real-world…

Whether it’s from our HQ in NYC or our new Life Science Hub in Raleigh-Durham, our teams are working together to accelerate cancer research and improve quality of care.

If you’re ready to be the next changemaker in cancer care, apply today: bit.ly/3ONI8pC

'Our vision is that tech is an asset to clinicians that are treating people with cancer, and is something that enables more time with those patients.'

Read more from Julia Morton, GM of Flatiron POC, on how tech, including #AI , is powering better care: hmpgloballearningnetwork.com/site/jcp/video…

Hear from Vice President of Scientific Engagement, Matt Reynolds, on our presence at this year’s ISPOR's #ISPORAnnual , including seven abstracts accepted for poster presentation.

Check out our event website or visit us at booth #319 to learn more: events.flatiron.com/ispor-us-2024

Medical Director Flatiron Health, Ivy Altomare, sat down with the ACCC & shared belief that tech is the key to streamlining #clinicaltrials & expanding accessibility.

Read more about Ivy’s experience & the tech driving change across the industry: accc-cancer.org/home/learn/res…

“Cancer continues to evolve, and if we aren’t willing to grow & challenge our thinking, we will always be one step behind.”

Read our recent #MeetOurChangemakers for a glimpse into Nick's journey, motivations, and work.

linkedin.com/pulse/meet-our…

ANNOUNCED TODAY: Flatiron Health to present a total of seven abstracts accepted for oral and poster presentation at this year’s ISPOR’s #ISPORAnnual

Learn more about our research:
events.flatiron.com/ispor-us-2024

Will Shapiro, Flatiron’s VP of Data Science, shared his thoughts with AJMC on the ethical concerns and regulatory considerations for the use of #AI tools, including #generativeAI , across the healthcare industry

Read more:
ajmc.com/view/will-shap…

THIS THURSDAY: join experts from Flatiron Health, Exact Sciences, and Johns Hopkins University, for an Endpoints News webinar covering multiple case studies on the application and regulatory considerations of #RWE & #RWD to streamline research.

Register now:
events.endpts.com/applying-real-…

Explore innovation in drug evaluation, AI/ML methods, and #RWE for HTAs in the latest issue from Frontiers - Pharmacology and Toxicology ⬇️

Read their recent ebook highlighting a collection of research and perspectives & uncovering insights from top industry experts: frontiersin.org/research-topic…

Join regulatory experts from Flatiron Health, Exact Sciences, and Johns Hopkins University, for an Endpoints News webinar on Thursday, April 25th to breakdown recent FDA guidance and learn how #RWD & #RWE can streamline #clinicalresearch .

Register now: events.endpts.com/applying-real-…

Flatiron Health UK's Adam Manhi joined CuriaUK for a roundtable on data's role in cancer—sharing how we use #RWD to create a deep network for research, driving new opportunities for biopharma & returning insights to the @NHS to improve care.

Learn more: flatironhealth.co.uk

Most #MM induction treatments involve bortezomib given twice-weekly, but recent research shows once-weekly may be as effective + fewer side effects. A study publshd in Blood Cancer Journal examines how the drug is currently used & effectiveness in real-world.

flatiron.com/resources/bort…

After learning about David Fajgenbaum, MD's unique journey with Castleman disease, Flatiron engineers used ML to better leverage Flatiron data, unlocking insights for a rare patient population.

Read our #LearnTeachGrow article for a behind the scenes look:
linkedin.com/pulse/using-ma…

ANNOUNCED TODAY: Flatiron is expanding their collaboration with National Comprehensive Cancer Network (NCCN) to further enable research with #RWD , create meaningful impact on cancer care, & allow cancer centers access to data sets to evaluate & enhance the quality of care given at their sites.
flatiron.com/resources/nccn…

Head of Healthcare Quality & Safety at Flatiron Health shared with AJMC that he sees it necessary for health care vendors and providers to consider the risk & safety of AI tools as the industry awaits the roll out of more regulations.

Read more: ajmc.com/view/dr-stephe…